Invention Grant
- Patent Title: Methods for one-dose intradermal delivery for non-live trivalent influenza vaccine
- Patent Title (中): 用于非活三价流感疫苗的一剂皮内递送方法
-
Application No.: US13271839Application Date: 2011-10-12
-
Publication No.: US09138471B2Publication Date: 2015-09-22
- Inventor: Nathalie Garcon , Moncef Mohamed Slaoui , Christian Van Hoecke
- Applicant: Nathalie Garcon , Moncef Mohamed Slaoui , Christian Van Hoecke
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals, S.A.
- Current Assignee: GlaxoSmithKline Biologicals, S.A.
- Current Assignee Address: BE Rixensart
- Agent Michael M. Conger
- Priority: GB0104538.4 20010223; GB0107511.8 20010326; GB0108365.8 20010403
- Main IPC: A61K39/145
- IPC: A61K39/145 ; A61K39/00
Abstract:
The invention relates to methods for one-dose influenza vaccine for intradermal delivery of a trivalent, non-live influenza antigen preparation, particularly a split influenza preparation.
Public/Granted literature
- US20120039933A1 METHODS FOR ONE-DOSE INTRADERMAL DELIVERY FOR NON-LIVE TRIVALENT INFLUENZA VACCINE Public/Granted day:2012-02-16
Information query
